Biokarpet Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Biokarpet.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Metals and Mining earnings growth15.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

The Return Trends At Biokarpet (ATH:BIOKA) Look Promising

Apr 13
The Return Trends At Biokarpet (ATH:BIOKA) Look Promising

Biokarpet's (ATH:BIOKA) Returns On Capital Are Heading Higher

Nov 09
Biokarpet's (ATH:BIOKA) Returns On Capital Are Heading Higher

Biokarpet (ATH:BIOKA) Seems To Be Using A Lot Of Debt

Oct 10
Biokarpet (ATH:BIOKA) Seems To Be Using A Lot Of Debt

Biokarpet S.A. (ATH:BIOKA) Doing What It Can To Lift Shares

Sep 09
Biokarpet S.A. (ATH:BIOKA) Doing What It Can To Lift Shares

Biokarpet (ATH:BIOKA) Might Have The Makings Of A Multi-Bagger

Jul 11
Biokarpet (ATH:BIOKA) Might Have The Makings Of A Multi-Bagger

Biokarpet (ATH:BIOKA) Is Doing The Right Things To Multiply Its Share Price

Mar 23
Biokarpet (ATH:BIOKA) Is Doing The Right Things To Multiply Its Share Price

Do Biokarpet's (ATH:BIOKA) Earnings Warrant Your Attention?

Sep 14
Do Biokarpet's (ATH:BIOKA) Earnings Warrant Your Attention?

Here's Why I Think Biokarpet (ATH:BIOKA) Is An Interesting Stock

Jun 04
Here's Why I Think Biokarpet (ATH:BIOKA) Is An Interesting Stock

Investors Will Want Biokarpet's (ATH:BIOKA) Growth In ROCE To Persist

Dec 09
Investors Will Want Biokarpet's (ATH:BIOKA) Growth In ROCE To Persist

Is Biokarpet (ATH:BIOKA) Using Too Much Debt?

Oct 21
Is Biokarpet (ATH:BIOKA) Using Too Much Debt?

Biokarpet (ATH:BIOKA) Is Experiencing Growth In Returns On Capital

Jun 03
Biokarpet (ATH:BIOKA) Is Experiencing Growth In Returns On Capital

Does Biokarpet (ATH:BIOKA) Have The Makings Of A Multi-Bagger?

Feb 23
Does Biokarpet (ATH:BIOKA) Have The Makings Of A Multi-Bagger?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Biokarpet has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ATSE:BIOKA - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20232184717N/A
3/31/20232257111N/A
12/31/20222319-65N/A
9/30/20222309-75N/A
6/30/20222299-95N/A
3/31/20222087-67N/A
12/31/20211874-39N/A
9/30/20211714-64N/A
6/30/20211554-90N/A
3/31/20211392-11-3N/A
12/31/20201230-14-5N/A
9/30/2020119-1-52N/A
6/30/2020116-249N/A
3/31/2020121039N/A
12/31/2019126139N/A
9/30/2019127118N/A
6/30/20191282-16N/A
3/31/20191241-15N/A
12/31/20181190-13N/A
9/30/20181160-22N/A
6/30/2018113-1-30N/A
3/31/2018109-1-21N/A
12/31/2017105-102N/A
9/30/2017100-102N/A
6/30/201795002N/A
3/31/201790-1N/A3N/A
12/31/201686-2N/A3N/A
9/30/201687-3N/A5N/A
6/30/201686-4N/A6N/A
3/31/201685-4N/A5N/A
12/31/201581-4N/A2N/A
9/30/201580-3N/A3N/A
6/30/201578-4N/A1N/A
3/31/201575-6N/A-1N/A
12/31/201474-7N/A-2N/A
9/30/201473-9N/A-2N/A
6/30/201473-9N/A0N/A
3/31/201473-9N/A1N/A
12/31/201372-10N/A3N/A
9/30/201377-10N/A1N/A
6/30/201379-11N/A1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if BIOKA's forecast earnings growth is above the savings rate (2.4%).

Earnings vs Market: Insufficient data to determine if BIOKA's earnings are forecast to grow faster than the Greek market

High Growth Earnings: Insufficient data to determine if BIOKA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if BIOKA's revenue is forecast to grow faster than the Greek market.

High Growth Revenue: Insufficient data to determine if BIOKA's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BIOKA's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.